NEWS
MIRA LAUNCHES MENOPAUSE TRANSITIONS KIT TO HELP WOMEN PREPARE FOR EARLY SYMPTOMS
Mira , a leading provider of hormonal health solutions for women , has launched the Menopause Transitions Kit . This AI-based hormone tracking monitor is the most comprehensive device for women to navigate at home how their hormones transition from the late reproductive stage and earliest perimenopause to postmenopause . Menopause affects around 47 million people annually , with about 47 % of women experiencing the first symptoms of perimenopause in their mid-thirties-forties , according to the Mira study .
While women admit menopause dramatically affects their lives , more than half still don ’ t know the symptoms associated with the transition . Thus , over 80 % of women do not know or even have a basic understanding of menopause .
Mira ’ s Menopause Transitions Kit is an AI-based at-home hormone monitor that tracks four key reproductive hormones ( FSH , E3G , PdG , LH ). Additionally , Mira launches a Menopause Transitions mode in its app for Mira Kit users . It will use customer data to define the current reproductive stage , anticipate approaching menopause , and offer insights to follow . Menopause Transitions Kit and Menopause app mode address a significant gap in menopause prediction solutions on the market .
Sylvia Kang , CEO of Mira , said : “ Unfortunately , menopause remains a deeply stigmatised issue , accompanied by the lack of education for women and helpful tools to prepare . By launching the menopause transition kit , we aim to offer women a solution that informs and empowers them . While many existing solutions only address the problem when it already exists , Mira Hormone Monitor : Menopause Transitions Kit provides an opportunity to enter and go through the whole menopause journey without guessing , address symptoms earlier , and better understand the changes that are such a normal part of ageing ”.
ROCHE LAUNCHES THE FIRST TEST TO USE ITS BREAKTHROUGH TAGS TECHNOLOGY FOR HIGH THROUGHPUT , SIMULTANEOUS DETECTION OF 12 RESPIRATORY VIRUSES important when a common group of symptoms can be related to more than one pathogen .
“ Many respiratory illnesses share similar symptoms , making them difficult to diagnose . As respiratory outbreaks , combined with growing incidence of antibiotic resistance continue , getting an accurate and timely diagnosis is critical to providing the best care for patients and curbing transmission ,” said Matt Sause , CEO of Roche Diagnostics . “ Using TAGS technology , the cobas Respiratory flex test can help clinicians identify specific respiratory viruses sooner , helping to speed up diagnosis and get the right care to patients .”
Roche has announced the launch of the cobas Respiratory flex test , the first to use Roche ’ s novel and proprietary TAGS ( Temperature-Activated Generation of Signal ) technology .
TAGS technology , developed by Roche scientists , uses multiplex polymerase chain reaction ( PCR ) testing , combined with colour , temperature and data processing , to identify as many as 15 pathogens in a single PCR test . Typically , PCR tests on a high throughput analyser are able to identify four results in a single test - TAGS technology makes it possible to increase this number to fifteen . This will enable syndromic panel testing on the high throughput molecular diagnostic analysers cobas 5800 , 6800 and 8800 , which is especially
www . intelligenthealth . tech 11